 |
Sorivudine |
|---|---|
| Trade Name | Bravavir |
| Orphan Indication | Herpes zoster (shingles) in immunocompromised patients |
| USA Market Approval | USA |
| USA Designation Date | 1995-11-09 00:00:00 |
| Sponsor | Bristol-Myers Squibb;5 Research Parkway, P.O. Box 5100;Wallingford, Connecticut, 06492 |
